Prophylactic cranial irradiation in locally advanced non-small cell lung cancer: Outcome of recursive partitioning analysis group 1 patients

Journal of Experimental and Clinical Cancer Research

Volumn 27, Issue 1, 2008, Pages

  Yavuz, Ali Aydin ^a   Topkan, Erkan ^a   Onal, Cem ^a   Yavuz, Melek Nur ^a  

^a BASKENT UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; DOCETAXEL;

ADRENAL METASTASIS; ADULT; ADVANCED CANCER; AGED; ARTICLE; BRAIN METASTASIS; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; LIVER METASTASIS; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RADIATION DOSE; SKULL IRRADIATION; TREATMENT FAILURE; TREATMENT OUTCOME; BRAIN TUMOR; DISEASE FREE SURVIVAL; LUNG TUMOR; METASTASIS; METHODOLOGY; MIDDLE AGED; PATHOLOGY;

ADULT; AGED; BRAIN NEOPLASMS; CARCINOMA, NON-SMALL-CELL LUNG; CRANIAL IRRADIATION; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED;

EID: 58149159406     PISSN: None     EISSN: 17569966     Source Type: Journal    
DOI: 10.1186/1756-9966-27-80     Document Type: Article

References (33)

1. Concurrent cisplatin/etoposide plus chest radiotherapy followed by surgery for stages IIIA (N2) and IIIB non-small-cell lung cancer: mature results of Southwest Oncology Group phase II study 8805. KS Albain VW Rusch JJ Crowley TW Rice AT Turrisi 3rd JK Weick VA Lonchyna CA Presant RJ McKenna DR Gandara, J Clin Oncol 1995 13 1880 1892 7636530
2. Patterns of relapse of N2 nonsmall-cell lung carcinoma patients treated with preoperative chemotherapy: should prophylactic cranial irradiation be reconsidered? F Andre D Grunenwald JL Pujol P Girard A Dujon L Brouchet PY Brichon V Westeel T Le Chevalier, Cancer 2001 91 2394 2400 10.1002/1097- 0142(20010615)91:12<2394::AID-CNCR1273>3.0.CO;2-6 11413530
3. Risk of cerebral metastases and neurological death after pathological complete response to neoadjuvant therapy for locally advanced nonsmall-cell lung cancer: clinical implications for the subsequent management of the brain. AM Chen TM Jahan DM Jablons J Garcia DA Larson, Cancer 2007 15,109 1668 1675 10.1002/cncr.22565
4. Neoadjuvant chemotherapy and radiotherapy followed by surgery in stage IIIA non-small cell carcinoma of the lung: Report of a Cancer and Leukemia Group B phase II study. GM Strauss JE Herndon DD Sherman DJ Mathisen RW Carey NC Choi VB Rege C Modeas MR Green, J Clin Oncol 1992 10 1237 1244 1321893
5. Addition of chemotherapy to radiation therapy alters failure patterns by cell type within non-small cell carcinoma of lung (NSCCL): Analysis of Radiation Therapy Oncology Group (RTOG) trials. JD Cox CB Scott RW Byhardt B Emami AH Russell KK Fu MB Parliament R Komaki LE Gaspar, Int J Radiat Oncol Biol Phys 1999 43 3 505 509 10078629
6. Prophylactic cranial irradiation for lung cancer patients at high risk for development of cerebral metastasis: Results of a prospective randomized trial conducted by the Radiation Therapy Oncology Group. AH Russell TE Pajak HM Selim JC Paradelo K Murray P Bansal JD Cooper S Silverman JA Clement, Int J Radiat Oncol Biol Phys 1991 21 3 637 643 1651304
7. Role of elective brain irradiation during combined chemoradiotherapy for limited disease non-small cell lung cancer. T Umsawasdi M Valdivieso TT Chen HT Barkley Jr DJ Booser DF Chiuten HM Dhingra WK Murphy CL Dixon P Farha, J Neuro-Oncol 1984 2 253 259 10.1007/BF00253278
8. Radiation Therapy Oncology Group (RTOG) 88-08 and Eastern Cooperative Oncology Group (ECOG) 4588: Preliminary results of a phase III trial in regionally advanced, unresectable nonsmall-cell lung cancer. WT Sause C Scott S Taylor D Johnson R Livingston R Komaki B Emami WJ Curran RW Byhardt AT Turrisi, J Natl Cancer Inst 1995 87 3 198 205 10.1093/jnci/87.3.198 7707407
9. Improved survival in stage III non-small-cell lung cancer: Seven-year follow-up of Cancer and Leukemia Group B (CALGB) 8433 trial. RO Dillman J Herndon SL Seagren WL Eaton Jr MR Green, J Natl Cancer Inst 1996 88 17 1210 1215 10.1093/jnci/88.17.1210 8780630
10. Prophylactic cranial irradiation in locally advanced non-small-cell lung cancer after multimodality treatment: long-term follow-up and investigations of late neuropsychologic effects. M Stuschke W Eberhardt C Pöttgen G Stamatis H Wilke G Stüben F Stöblen HH Wilhelm H Menker H Teschler RD Müller V Budach S Seeber H Sack, J Clin Oncol 1999 17 2700 2709 10561344
11. The role of prophylactic cranial irradiation in regionally advanced non-small cell lung cancer. A Southwest Oncology Group Study. VW Rusch BR Griffin RB Livingston, J Thorac Cardiovasc Surg 1989 98 4 535 539 2552227
12. Neoadjuvant chemotherapy in marginally resectable stage III M0 non-small cell lung cancer: Long-term follow-up in 41 patients. A Skarin M Jochelson T Sheldon A Malcolm P Oliynyk R Overholt M Hunt E Frei 3rd, J Surg Oncol 1989 40 4 266 274 10.1002/jso.2930400413 2538680
13. Cranial irradiation in cancer of the lung of all cell types. JD Cox K Stanley Z Petrovich C Paig R Yesner, JAMA 1981 245 469 472 10.1001/jama.245.5. 469 7452872
14. Prophylactic cranial irradiation in operable stage IIIA non-small-cell lung cancer treated with neoadjuvant chemoradiotherapy: Results from a Geman multicenter trial. C Pöttgen W Eberhardt A Grannass S Korfee G Stüben H Teschler G Stamatis H Wagner B Passlick V Petersen V Budach H Wilhelm I Wanke H Hirche HJ Wilke M Stuschke, J Clin Oncol 2007 25 4987 4992 10.1200/JCO.2007.12.5468 17971598
15. Factors affecting the risk of brain metastases after definitive chemoradiation for locally advanced non-small-cell lung carcinoma. TJ Robnett M Machtay JP Stevenson KM Algazy SM Hahn, J Clin Oncol 2001 19 1344 1349 11230477
16. Emergence of increased cerebral metastasis after high-dose preoperative radiotherapy with chemotherapy in patients with locally advanced non-small cell lung carcinoma. A Law DD Karp T Dipetrillo BT Daly, Cancer 2001 92 160 164 10.1002/1097-0142(20010701)92:1<160::AID-CNCR1304>3.0.CO;2-X 11443622
17. Brain metastases in locally advanced nonsmall cell lung carcinoma after multimodality treatment: risk factors analysis. GL Ceresoli M Reni G Chiesa A Carretta S Schipani P Passoni A Bolognesi P Zannini E Villa, Cancer 2002 95 605 612 10.1002/cncr.10687 12209754
18. Does the incidence and outcome of brain metastases in locally advanced non-small cell lung cancer justify prophylactic cranial irradiation or early detection? H Carolan AY Sun A Bezjak QL Yi D Payne G Kane J Waldron N Leighl R Feld R Burkes S Keshavjee F Shepherd, Lung Cancer 2005 49 109 115 10.1016/j.lungcan.2004.12.004 15949596
19. Failure patterns by prognostic group determined by recursive partitioning analysis (RPA) of 1547 patients on four Radiation Therapy Oncology Group (RTOG) studies in inoperable non-small-cell lung cancer. R Komaki CB Scott R Byhardt B Emami SO Asbell AH Russell M Roach MB Parliament LE Gaspar, Int J Radiat Oncol Biol Phys 1998 42 2 263 267 9788403
20. Recursive partitioning analysis of 1999 Radiation Therapy Oncology Group (RTOG) patients with locally-advanced non-small-cell lung cancer (LA-NSCLC): identification of five groups with different survival. M Werner-Wasik C Scott JD Cox WT Sause RW Byhardt S Asbell A Russell R Komaki JS Lee, Int J Radiat Oncol Biol Phys 2000 48 1475 1482 11121651
21. Potential impact on survival of improved tumor downstaging and resection rate by preoperative twice-daily radiation and concurrent chemotherapy in stage IIIA non-smallcell lung cancer. NC Choi RW Carey W Daly D Mathisen J Wain C Wright T Lynch M Grossbard H Grillo, J Clin Oncol 1997 15 712 722 9053497
22. Preoperative chemotherapy followed by concurrent chemoradiation therapy based on hyperfractionated accelerated radiation therapy and definitive surgery in locally advanced non-small-cell lung cancer: Mature results of a phase II trial. W Eberhardt H Wilke G Stamatis M Stuschke A Harstrick H Menker B Krause MR Müeller M Stahl M Flasshove V Budach D Greschuchna N Konietzko H Sack S Seeber, J Clin Oncol 1998 16 622 634 9469351
23. Time from treatment to subsequent diagnosis of brain metastasis in stage III non-small-cell lung cancer. A retrospective review by the Southwest Oncology Group. LE Gaspar K Chansky KS Albain E Vallieres V Rusch JJ Crowley RB Livingston DR Gandara, J Clin Oncol 2005 23 2955 2961 10.1200/JCO.2005.08.026 15860851
24. High risk of brain metastases in surgically staged IIIA non-small-cell lung cancer patients treated with surgery, chemotherapy, and radiation. HJ Mamon BY Yeap PA Jänne J Reblando S Shrager MT Jaklitsch S Mentzer JM Lukanich DJ Sugarbaker EH Baldini S Berman A Skarin R Bueno, J Clin Oncol 2005 23 1530 1537 10.1200/JCO.2005.04.123 15735128
25. Definitive chemoradiation for the treatment of locally advanced non small-cell lung cancer. AW Blackstock R Govindan, J Clin Oncol 2007 25 4146 4152 10.1200/JCO.2007.12.6581 17827465
26. Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. A Auperin R Arriagada JP Pignon C Le Pechoux A Gregor RJ Stephens, NEJM 1999 341 7 476 484 10.1056/NEJM199908123410703 10441603
27. Neurological and cognitive impairment in long-term survivors of small cell lung cancer. A Cull A Gregor P Hopwood F Macbeth H Karnicka-Mlodkowska N Thatcher P Burt R Stout K Stepniewska M Stewart, Eur J Cancer 1994 30 1067 1064 10.1016/0959-8049(94)90458-8
28. Neurologic, neuropsychologic, and computed cranial tomography scan abnormalities in 2- to 10-year survivors of small-cell lung cancer. BE Johnson B Becker WB Goff 2nd N Petronas MA Krehbiel RW Makuch G McKenna E Glatstein DC Ihde, J Clin Oncol 1985 3 1659 1667 2999346
29. Neurologic, computed cranial tomographic, and magnetic resonance imaging abnormalities in patients with small-cell lung cancer: further follow-up of 6- to 13-year survivors. BE Johnson N Patronas W Hayes J Grayson B Becker D Gnepp J Rowland A Anderson E Glatstein DC Ihde, J Clin Oncol 1990 8 48 56 2153196
30. Neurologic disorders in 203 consecutive patients with small cell lung cancer. Results of a longitudinal study. AG van Oosterhout M van de Pol GP ten Velde A Twijnstra, Cancer 1996 77 1434 1441 10.1002/(SICI)1097-0142(19960415)77: 8<1434::AID-CNCR3>3.0.CO;2-C 8608526
31. Prophylactic cranial irradiation is indicated following complete response to induction therapy in small cell lung cancer: results of a multicentre randomised trial. United Kingdom Coordinating Committee for Cancer Research (UKCCCR) and the European Organization for Research and Treatment of Cancer (EORTC). A Gregor A Cull RJ Stephens JA Kirkpatrick JR Yarnold DJ Girling FR Macbeth R Stout D Machin, Eur J Cancer 1997 33 1752 1758 10.1016/S0959-8049(97) 00135-4 9470828
32. Patterns of failure after prophylactic cranial irradiation in small-cell lung cancer: analysis of 505 randomized patients. R Arriagada T Le Chevalier A Rivière P Chomy I Monnet E Bardet JA Santos-Miranda C Le Péhoux M Tarayre S Benhamou A Laplanche, Ann Oncol 2002 13 748 754 10.1093/annonc/mdf123 12075744
33. Simultaneous chemotherapy-radiotherapy with prophylactic cranial irradiation for inoperable adeno and large cell lung carcinoma: a Southwest Oncology Group Study. JG Mira SL Taylor RL Stephens T Chen, Int J Radiat Oncol Biol Phys 1988 15 3 757 761 2843490